Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives

  • Molina-Montes, Esther
  • Gomez-Rubio, Paulina
  • Marquez, Mirari
  • Rava, Marta
  • Löhr, Matthias
  • Michalski, Christoph W.
  • Molero, Xavier
  • Farré, Antoni
  • Perea, José
  • Greenhalf, William
  • Ilzarbe, L.
  • O'Rorke, Michael
  • Tardón, Adonina
  • Gress, Thomas
  • Barberá, Víctor Manuel
  • Crnogorac-Jurcevic, Tatjana
  • Domínguez-Muñoz, Enrique
  • Muñoz-Bellvís, Luís
  • Balsells, Joaquim
  • Costello, Eithne
  • Huang, J.
  • Iglesias, Mar
  • Kleeff, Jörg
  • Kong, Bo
  • Mora, Josefina
  • Murray, Liam
  • O'Driscoll, Damian
  • Poves, Ignasi
  • Scarpa, Aldo
  • Ye, Weimin
  • Hidalgo, Manuel
  • Sharp, Linda
  • Carrato, Alfredo
  • Real, Francisco X.
  • Malats, Núria
  • Barberá, Víctor Manuel|||/items/014ad996-9d09-431d-8340-f09dde20b90b
Background: Family history (FH) of pancreatic cancer (PC) has been associated with an increased risk of PC, but little is known regarding the role of inherited/environmental factors or that of FH of other comorbidities in PC risk. We aimed to address these issues using multiple methodological approaches. Methods: Case-control study including 1431 PC cases and 1090 controls and a reconstructed-cohort study (N = 16 747) made up of their first-degree relatives (FDR). Logistic regression was used to evaluate PC risk associated with FH of cancer, diabetes, allergies, asthma, cystic fibrosis and chronic pancreatitis by relative type and number of affected relatives, by smoking status and other potential effect modifiers, and by tumour stage and location. Familial aggregation of cancer was assessed within the cohort using Cox proportional hazard regression. Results: FH of PC was associated with an increased PC risk [odds ratio (OR) = 2.68; 95% confidence interval (CI): 2.27-4.06] when compared with cancer-free FH, the risk being greater when ≥ 2 FDRs suffered PC (OR = 3.88; 95% CI: 2.96-9.73) and among current smokers (OR = 3.16; 95% CI: 2.56-5.78, interaction FHPC*smoking P-value = 0.04). PC cumulative risk by age 75 was 2.2% among FDRs of cases and 0.7% in those of controls [hazard ratio (HR) = 2.42; 95% CI: 2.16-2.71]. PC risk was significantly associated with FH of cancer (OR = 1.30; 95% CI: 1.13-1.54) and diabetes (OR = 1.24; 95% CI: 1.01-1.52), but not with FH of other diseases. Conclusions: The concordant findings using both approaches strengthen the notion that FH of cancer, PC or diabetes confers a higher PC risk. Smoking notably increases PC risk associated with FH of PC. Further evaluation of these associations should be undertaken to guide PC prevention strategies.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk

  • Gomez-Rubio, Paulina
  • Rosato, V.
  • Marquez, Mirari
  • Bosetti, C.
  • Molina-Montes, Esther
  • Rava, Marta
  • Piñero, Janet
  • Michalski, Christoph W.
  • Farré, Antoni
  • Molero, Xavier
  • Löhr, Matthias
  • Ilzarbe, L.
  • Perea, José
  • Greenhalf, William
  • O’Rorke, Michael
  • Tardón, Adonina
  • Gress, Thomas
  • Barberá, Víctor Manuel
  • Crnogorac-Jurcevic, Tatjana
  • Muñoz-Bellvís, Luís
  • Domínguez-Muñoz, Enrique
  • Gutiérrez-Sacristán, Alba
  • Balsells, Joaquim
  • Costello, Eithne
  • Guillén-Ponce, Carmen
  • Huang, J.
  • Iglesias, Mar
  • Kleeff, Jörg
  • Kong, Bo
  • Mora, Josefina
  • Murray, Liam
  • O’Driscoll, Damian
  • Peláez, P.
  • Poves, Ignasi
  • Lawlor, Rita T.
  • Carrato, Alfredo
  • Hidalgo, Manuel
  • Scarpa, Aldo
  • Sharp, Linda
  • Furlong, Laura I.
  • Real, Francisco X.
  • La Vecchia, C.
  • Malats, Núria
  • Barberá, Víctor Manuel|||/items/014ad996-9d09-431d-8340-f09dde20b90b
Background: Pancreatic ductal adenocarcinoma (PDAC) is usually diagnosed in late adulthood; therefore, many patients suffer or have suffered from other diseases. Identifying disease patterns associated with PDAC risk may enable a better characterization of high-risk patients. Methods: Multimorbidity patterns (MPs) were assessed from 17 self-reported conditions using hierarchical clustering, principal component, and factor analyses in 1705 PDAC cases and 1084 controls from a European population. Their association with PDAC was evaluated using adjusted logistic regression models. Time since diagnosis of morbidities to PDAC diagnosis/recruitment was stratified into recent (<3 years) and long term (≥3 years). The MPs and PDAC genetic networks were explored with DisGeNET bioinformatics-tool which focuses on gene-diseases associations available in curated databases. Results: Three MPs were observed: gastric (heartburn, acid regurgitation, Helicobacter pylori infection, and ulcer), metabolic syndrome (obesity, type-2 diabetes, hypercholesterolemia, and hypertension), and atopic (nasal allergies, skin allergies, and asthma). Strong associations with PDAC were observed for ≥2 recently diagnosed gastric conditions [odds ratio (OR), 6.13; 95% confidence interval CI 3.01–12.5)] and for ≥3 recently diagnosed metabolic syndrome conditions (OR, 1.61; 95% CI 1.11–2.35). Atopic conditions were negatively associated with PDAC (high adherence score OR for tertile III, 0.45; 95% CI, 0.36–0.55). Combining type-2 diabetes with gastric MP resulted in higher PDAC risk for recent (OR, 7.89; 95% CI 3.9–16.1) and long-term diagnosed conditions (OR, 1.86; 95% CI 1.29–2.67). A common genetic basis between MPs and PDAC was observed in the bioinformatics analysis. Conclusions: Specific multimorbidities aggregate and associate with PDAC in a time-dependent manner. A better characterization of a high-risk population for PDAC may help in the early diagnosis of this cancer. The common genetic basis between MP and PDAC points to a mechanistic link between these conditions.